Annual Revenue
$509.79 M
+$20.05 M+4.10%
31 December 2023
Summary:
Core Laboratories NV annual revenue is currently $509.79 million, with the most recent change of +$20.05 million (+4.10%) on 31 December 2023. During the last 3 years, it has risen by +$22.52 million (+4.62%). CLB annual revenue is now -53.02% below its all-time high of $1.09 billion, reached on 31 December 2014.CLB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$134.40 M
+$3.82 M+2.93%
30 September 2024
Summary:
Core Laboratories NV quarterly revenue is currently $134.40 million, with the most recent change of +$3.82 million (+2.93%) on 30 September 2024. Over the past year, it has increased by +$9.05 million (+7.22%). CLB quarterly revenue is now -51.76% below its all-time high of $278.62 million, reached on 31 December 2014.CLB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$522.82 M
+$9.05 M+1.76%
30 September 2024
Summary:
Core Laboratories NV TTM revenue is currently $522.82 million, with the most recent change of +$9.05 million (+1.76%) on 30 September 2024. Over the past year, it has increased by +$13.67 million (+2.68%). CLB TTM revenue is now -51.82% below its all-time high of $1.09 billion, reached on 31 December 2014.CLB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.1% | +7.2% | +2.7% |
| 3 y3 years | +4.6% | +13.9% | +13.9% |
| 5 y5 years | -27.3% | -22.4% | -23.6% |
CLB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +8.4% | at high | +16.6% | at high | +13.9% |
| 5 y | 5 years | -27.3% | +8.4% | -22.4% | +27.5% | -23.6% | +17.9% |
| alltime | all time | -53.0% | +536.4% | -51.8% | +655.0% | -51.8% | +2837.2% |
Core Laboratories NV Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $134.40 M(+2.9%) | $522.82 M(+1.8%) |
| June 2024 | - | $130.58 M(+0.7%) | $513.77 M(+0.5%) |
| Mar 2024 | - | $129.64 M(+1.1%) | $511.07 M(+0.3%) |
| Dec 2023 | $509.79 M(+4.1%) | $128.21 M(+2.3%) | $509.79 M(+0.1%) |
| Sept 2023 | - | $125.34 M(-2.0%) | $509.15 M(-0.1%) |
| June 2023 | - | $127.88 M(-0.4%) | $509.77 M(+1.4%) |
| Mar 2023 | - | $128.36 M(+0.6%) | $502.79 M(+2.7%) |
| Dec 2022 | $489.74 M(+4.1%) | $127.57 M(+1.3%) | $489.74 M(+0.5%) |
| Sept 2022 | - | $125.97 M(+4.2%) | $487.30 M(+1.7%) |
| June 2022 | - | $120.90 M(+4.9%) | $479.32 M(+0.5%) |
| Mar 2022 | - | $115.30 M(-7.9%) | $477.17 M(+1.5%) |
| Dec 2021 | $470.25 M(-3.5%) | $125.14 M(+6.1%) | $470.25 M(+2.5%) |
| Sept 2021 | - | $117.98 M(-0.6%) | $458.86 M(+2.8%) |
| June 2021 | - | $118.75 M(+9.6%) | $446.26 M(+0.7%) |
| Mar 2021 | - | $108.38 M(-4.7%) | $443.25 M(-9.0%) |
| Dec 2020 | $487.27 M(-27.1%) | $113.75 M(+7.9%) | $487.27 M(-8.1%) |
| Sept 2020 | - | $105.38 M(-8.9%) | $530.30 M(-11.3%) |
| June 2020 | - | $115.74 M(-24.1%) | $598.11 M(-8.2%) |
| Mar 2020 | - | $152.40 M(-2.8%) | $651.42 M(-2.5%) |
| Dec 2019 | $668.21 M(-4.7%) | $156.78 M(-9.5%) | $668.21 M(-2.4%) |
| Sept 2019 | - | $173.20 M(+2.5%) | $684.64 M(-1.3%) |
| June 2019 | - | $169.04 M(-0.1%) | $693.59 M(-0.9%) |
| Mar 2019 | - | $169.19 M(-2.3%) | $700.02 M(-0.1%) |
| Dec 2018 | $700.85 M(+8.2%) | $173.21 M(-4.9%) | $700.85 M(+0.4%) |
| Sept 2018 | - | $182.15 M(+3.8%) | $697.75 M(+2.8%) |
| June 2018 | - | $175.47 M(+3.2%) | $678.49 M(+2.6%) |
| Mar 2018 | - | $170.02 M(-0.1%) | $661.23 M(+2.1%) |
| Dec 2017 | $647.82 M(+9.8%) | $170.11 M(+4.4%) | $647.82 M(+4.0%) |
| Sept 2017 | - | $162.89 M(+3.0%) | $622.74 M(+3.2%) |
| June 2017 | - | $158.21 M(+1.0%) | $603.34 M(+1.7%) |
| Mar 2017 | - | $156.61 M(+8.0%) | $593.19 M(+0.5%) |
| Dec 2016 | $590.23 M(-26.0%) | $145.03 M(+1.1%) | $590.23 M(-6.0%) |
| Sept 2016 | - | $143.48 M(-3.1%) | $627.92 M(-7.9%) |
| June 2016 | - | $148.07 M(-3.6%) | $681.70 M(-7.6%) |
| Mar 2016 | - | $153.65 M(-15.9%) | $737.52 M(-7.5%) |
| Dec 2015 | $797.52 M(-26.5%) | $182.72 M(-7.4%) | $797.52 M(-10.7%) |
| Sept 2015 | - | $197.26 M(-3.2%) | $893.42 M(-8.1%) |
| June 2015 | - | $203.89 M(-4.6%) | $972.29 M(-6.1%) |
| Mar 2015 | - | $213.64 M(-23.3%) | $1.04 B(-4.5%) |
| Dec 2014 | $1.09 B(+1.1%) | $278.62 M(+0.9%) | $1.09 B(+0.2%) |
| Sept 2014 | - | $276.13 M(+3.2%) | $1.08 B(+0.3%) |
| June 2014 | - | $267.56 M(+1.8%) | $1.08 B(+0.4%) |
| Mar 2014 | - | $262.90 M(-4.8%) | $1.08 B(+0.2%) |
| Dec 2013 | $1.07 B(+9.4%) | $276.28 M(+1.1%) | $1.07 B(+2.1%) |
| Sept 2013 | - | $273.16 M(+3.8%) | $1.05 B(+2.7%) |
| June 2013 | - | $263.14 M(+0.8%) | $1.02 B(+1.6%) |
| Mar 2013 | - | $260.93 M(+2.5%) | $1.01 B(+2.7%) |
| Dec 2012 | $981.08 M(+8.1%) | $254.46 M(+3.7%) | $981.08 M(+1.1%) |
| Sept 2012 | - | $245.43 M(-0.6%) | $970.41 M(+1.5%) |
| June 2012 | - | $247.01 M(+5.5%) | $956.33 M(+2.3%) |
| Mar 2012 | - | $234.19 M(-3.9%) | $935.11 M(+3.0%) |
| Dec 2011 | $907.65 M(+14.2%) | $243.79 M(+5.4%) | $907.65 M(+4.1%) |
| Sept 2011 | - | $231.34 M(+2.5%) | $872.05 M(+3.8%) |
| June 2011 | - | $225.78 M(+9.2%) | $839.93 M(+3.3%) |
| Mar 2011 | - | $206.73 M(-0.7%) | $813.05 M(+2.3%) |
| Dec 2010 | $794.65 M(+14.2%) | $208.19 M(+4.5%) | $794.65 M(+3.5%) |
| Sept 2010 | - | $199.22 M(+0.2%) | $768.06 M(+4.3%) |
| June 2010 | - | $198.90 M(+5.6%) | $736.64 M(+4.5%) |
| Mar 2010 | - | $188.34 M(+3.7%) | $705.00 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $695.54 M(-10.9%) | $181.60 M(+8.2%) | $695.54 M(-2.7%) |
| Sept 2009 | - | $167.80 M(+0.3%) | $715.13 M(-4.6%) |
| June 2009 | - | $167.26 M(-6.5%) | $749.85 M(-3.9%) |
| Mar 2009 | - | $178.88 M(-11.1%) | $780.27 M(-0.1%) |
| Dec 2008 | $780.84 M(+16.4%) | $201.19 M(-0.7%) | $780.84 M(+3.3%) |
| Sept 2008 | - | $202.52 M(+2.4%) | $756.01 M(+4.5%) |
| June 2008 | - | $197.69 M(+10.2%) | $723.55 M(+4.2%) |
| Mar 2008 | - | $179.44 M(+1.7%) | $694.25 M(+3.5%) |
| Dec 2007 | $670.54 M(+16.5%) | $176.36 M(+3.7%) | $670.54 M(+3.6%) |
| Sept 2007 | - | $170.06 M(+1.0%) | $646.99 M(+3.9%) |
| June 2007 | - | $168.39 M(+8.1%) | $622.45 M(+4.8%) |
| Mar 2007 | - | $155.72 M(+1.9%) | $594.08 M(+3.2%) |
| Dec 2006 | $575.69 M(+19.1%) | $152.81 M(+5.0%) | $575.69 M(+4.3%) |
| Sept 2006 | - | $145.53 M(+3.9%) | $551.83 M(+4.8%) |
| June 2006 | - | $140.02 M(+2.0%) | $526.48 M(+4.3%) |
| Mar 2006 | - | $137.34 M(+6.5%) | $504.85 M(+4.4%) |
| Dec 2005 | $483.47 M(+13.1%) | $128.95 M(+7.3%) | $483.47 M(+2.7%) |
| Sept 2005 | - | $120.18 M(+1.5%) | $470.62 M(+2.5%) |
| June 2005 | - | $118.38 M(+2.1%) | $459.21 M(+3.6%) |
| Mar 2005 | - | $115.95 M(-0.1%) | $443.06 M(+3.7%) |
| Dec 2004 | $427.43 M(+14.5%) | $116.10 M(+6.7%) | $427.43 M(+4.1%) |
| Sept 2004 | - | $108.78 M(+6.4%) | $410.54 M(+2.8%) |
| June 2004 | - | $102.23 M(+1.9%) | $399.55 M(+3.0%) |
| Mar 2004 | - | $100.32 M(+1.1%) | $388.00 M(+4.0%) |
| Dec 2003 | $373.17 M(+12.8%) | $99.21 M(+1.5%) | $373.17 M(+9.3%) |
| Sept 2003 | - | $97.79 M(+7.8%) | $341.56 M(+1.6%) |
| June 2003 | - | $90.68 M(+6.1%) | $336.20 M(+1.0%) |
| Mar 2003 | - | $85.48 M(+26.5%) | $332.98 M(+0.1%) |
| Dec 2002 | $330.77 M(-12.2%) | $67.60 M(-26.9%) | $332.56 M(-8.1%) |
| Sept 2002 | - | $92.43 M(+5.7%) | $361.83 M(-1.3%) |
| June 2002 | - | $87.46 M(+2.8%) | $366.49 M(-1.0%) |
| Mar 2002 | - | $85.06 M(-12.2%) | $370.29 M(-1.7%) |
| Dec 2001 | $376.57 M(+10.5%) | $96.87 M(-0.2%) | $376.57 M(-3.1%) |
| Sept 2001 | - | $97.10 M(+6.4%) | $388.75 M(+3.2%) |
| June 2001 | - | $91.26 M(-0.1%) | $376.63 M(+3.0%) |
| Mar 2001 | - | $91.35 M(-16.2%) | $365.61 M(+5.5%) |
| Dec 2000 | $340.93 M(+4.6%) | $109.04 M(+28.3%) | $346.50 M(+3.4%) |
| Sept 2000 | - | $84.98 M(+5.9%) | $335.08 M(+1.2%) |
| June 2000 | - | $80.24 M(+11.1%) | $331.00 M(+0.8%) |
| Mar 2000 | - | $72.23 M(-26.0%) | $328.48 M(+1.6%) |
| Dec 1999 | $325.83 M(+2.7%) | $97.63 M(+20.7%) | $323.46 M(-0.2%) |
| Sept 1999 | - | $80.90 M(+4.1%) | $323.95 M(+0.2%) |
| June 1999 | - | $77.72 M(+15.6%) | $323.45 M(+2.5%) |
| Mar 1999 | - | $67.22 M(-31.5%) | $315.44 M(+1.5%) |
| Dec 1998 | $317.12 M(+34.7%) | $98.12 M(+22.0%) | $310.72 M(+0.3%) |
| Sept 1998 | - | $80.40 M(+15.4%) | $309.80 M(+6.7%) |
| June 1998 | - | $69.70 M(+11.5%) | $290.30 M(+6.9%) |
| Mar 1998 | - | $62.50 M(-35.7%) | $271.60 M(+14.6%) |
| Dec 1997 | $235.40 M(+111.3%) | $97.20 M(+59.6%) | $237.10 M(+36.0%) |
| Sept 1997 | - | $60.90 M(+19.4%) | $174.40 M(+25.5%) |
| June 1997 | - | $51.00 M(+82.1%) | $139.00 M(+24.8%) |
| Mar 1997 | - | $28.00 M(-18.8%) | $111.40 M(+2.3%) |
| Dec 1996 | $111.40 M(+39.1%) | $34.50 M(+35.3%) | $108.90 M(+12.7%) |
| Sept 1996 | - | $25.50 M(+9.0%) | $96.60 M(+4.4%) |
| June 1996 | - | $23.40 M(-8.2%) | $92.50 M(+5.5%) |
| Mar 1996 | - | $25.50 M(+14.9%) | $87.70 M(+9.6%) |
| Dec 1995 | $80.10 M | $22.20 M(+3.7%) | $80.00 M(+38.4%) |
| Sept 1995 | - | $21.40 M(+15.1%) | $57.80 M(+58.8%) |
| June 1995 | - | $18.60 M(+4.5%) | $36.40 M(+104.5%) |
| Mar 1995 | - | $17.80 M | $17.80 M |
FAQ
- What is Core Laboratories NV annual revenue?
- What is the all time high annual revenue for Core Laboratories NV?
- What is Core Laboratories NV annual revenue year-on-year change?
- What is Core Laboratories NV quarterly revenue?
- What is the all time high quarterly revenue for Core Laboratories NV?
- What is Core Laboratories NV quarterly revenue year-on-year change?
- What is Core Laboratories NV TTM revenue?
- What is the all time high TTM revenue for Core Laboratories NV?
- What is Core Laboratories NV TTM revenue year-on-year change?
What is Core Laboratories NV annual revenue?
The current annual revenue of CLB is $509.79 M
What is the all time high annual revenue for Core Laboratories NV?
Core Laboratories NV all-time high annual revenue is $1.09 B
What is Core Laboratories NV annual revenue year-on-year change?
Over the past year, CLB annual revenue has changed by +$20.05 M (+4.10%)
What is Core Laboratories NV quarterly revenue?
The current quarterly revenue of CLB is $134.40 M
What is the all time high quarterly revenue for Core Laboratories NV?
Core Laboratories NV all-time high quarterly revenue is $278.62 M
What is Core Laboratories NV quarterly revenue year-on-year change?
Over the past year, CLB quarterly revenue has changed by +$9.05 M (+7.22%)
What is Core Laboratories NV TTM revenue?
The current TTM revenue of CLB is $522.82 M
What is the all time high TTM revenue for Core Laboratories NV?
Core Laboratories NV all-time high TTM revenue is $1.09 B
What is Core Laboratories NV TTM revenue year-on-year change?
Over the past year, CLB TTM revenue has changed by +$13.67 M (+2.68%)